Detected ·

MAASH

€12.15M—

Brussels biotech MAASH secured a €12.15M funding package (€5.85M equity from Ambra Capital, InvestPro, Bpifrance, Bpifrance Amorçage Industriel, Nordzucker AG, and Tereos, plus €4.3M and a €2M loan from Bpifrance) to scale its LoCylia™ fermentation-derived mycoprotein for industrial production.

Amount
€12 150 000 EUR
Stage
—
Event
Funding round
Detected
2026-08-26 22:32:13 UTC
Signal ID
0b3454a3-ab67-4a9c-9b19-0658ed978a5b

As the API returns it

{
  "id": "0b3454a3-ab67-4a9c-9b19-0658ed978a5b",
  "created_at": "2026-08-26T22:32:13.022601Z",
  "company_name": "MAASH",
  "company_website_url": "www.maashcompany.com",
  "company_linkedin_url": "https://www.linkedin.com/company/maash",
  "event_type": "funding",
  "funding_amount": 12150000,
  "funding_currency": "EUR",
  "funding_stage": null,
  "message": "*Brussels biotech MAASH secured a €12.15M funding package (€5.85M equity from Ambra Capital, InvestPro, Bpifrance, Bpifrance Amorçage Industriel, Nordzucker AG, and Tereos, plus €4.3M and a €2M loan from Bpifrance) to scale its LoCylia™ fermentation-derived mycoprotein for industrial production.*"
}

Latest rounds